Latest Earnings Results: Q1 '27
Estimated EPS
---
Reported EPS
-$0.08
Surprise
---
Estimated Rev
---
Reported Rev
$0.2M
Surprise
---
• Reported GAAP EPS of -$0.07 • Reported revenue of $1.07M up 296.30% YoY • RenovoRx remains on target to deliver full year 2026 revenue in the range of $3.75M to $4.25M, based on current customer utilization trends, activation timelines, repeat ordering patterns and management assumptions.
Generated by Stocktwits using AI and company-reported earnings data for Q1 '27. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q2 '27 | -- | -$0.08 | -- | N/A |
Q1 '27 | -- | -$0.08 | -- | N/A |
Q4 '26 | -$0.06 | -- | -- | N/A |
Q3 '26 | -$0.06 | -$0.08 | -33.33% | MISSED |
Q2 '26 | -$0.07 | -$0.06 | 17.24% | BEAT |